MARY ANN GRAY
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
DIRECTOR
KENNETH CARTER, JOHN CONRON, CRISTINA CSIMMA, RICHARD DALY, STEPHANIE DIAZ, STEPHANIE C DIAZ, J.D. FINLEY, JD FINLEY, MARGERY FISCHBEIN, I. RICHARD GARR, RICHARD GARR, RICHARD I. GARR, THOMAS HALLAM, KARL JOHE, MITCHELL JONES, JONATHAN LLOYD JONES, DAVID MAZZO, ROBERT MCRAE, JAMES NEAL, JAMES R NEAL, SCOTT OGILVIE, WILLIAM OLDAKER, HERBERT SLADE, SANDFORD SMITH, SANDFORD D. SMITH, CATHERINE SOHN, CATHERINE A. SOHN, ROBERT TRENSCHEL, BINXIAN WEI, STANLEY WESTREICH, DONALD WILLIAMS
DIRECTOR
KENNETH CARTER, JOHN CONRON, CRISTINA CSIMMA, RICHARD DALY, STEPHANIE DIAZ, STEPHANIE C DIAZ, J.D. FINLEY, JD FINLEY, MARGERY FISCHBEIN, I. RICHARD GARR, RICHARD GARR, RICHARD I. GARR, THOMAS HALLAM, KARL JOHE, MITCHELL JONES, JONATHAN LLOYD JONES, DAVID MAZZO, ROBERT MCRAE, JAMES NEAL, JAMES R NEAL, SCOTT OGILVIE, WILLIAM OLDAKER, HERBERT SLADE, SANDFORD SMITH, SANDFORD D. SMITH, CATHERINE SOHN, CATHERINE A. SOHN, ROBERT TRENSCHEL, BINXIAN WEI, STANLEY WESTREICH, DONALD WILLIAMS
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2024-02-01
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2023-04-05
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2023-01-04
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2022-05-10
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-02-14
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2020-01-22
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-11-13
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2012-12-17
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2011-01-12

